@article{366be2ccde5c4ea8944f19ebadc9db79,
title = "Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes",
abstract = "A randomized clinical trial compared efficacy and toxicity of standard all-trans-retinoic acid (ATRA) plus chemotherapy versus ATRA plus arsenic trioxide in patients with newly diagnosed, low- or intermediate-risk acute promyelocytic leukemia (APL). Here, we report health-related quality-of-life (HRQOL) results.",
keywords = "allogeneic, allogeneic",
author = "Fabio Efficace and Franco Mandelli and Giuseppe Avvisati and Francesco Cottone and Felicetto Ferrara and \{Di Bona\}, Eros and Giorgina Specchia and Massimo Breccia and Alessandro Levis and Simona Sica and Olimpia Finizio and Kropp, \{Maria Grazia\} and Giuseppe Fioritoni and Elisa Cerqui and Marco Vignetti and Sergio Amadori and Schlenk, \{Richard F.\} and Uwe Platzbecker and Francesco Lo-Coco",
year = "2014",
doi = "10.1200/JCO.2014.55.3453",
language = "English",
volume = "32",
pages = "3406--3412",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "Lippincott Williams and Wilkins",
}